NVO and VKTX Related Headlines
Go Back- Novo Nordisk (NVO) stock: Barclays breaks down key investor questions and debates
- Truist Securities Reiterates Buy Rating on Viking Therapeutic (VKTX)
- Novo Nordisk, Eli Lilly rise after Viking obesity trial data
